- Category
- Small (2022-23)
- Udyam number
- UDYAM-UP-56-0004674

Gorakh Nath Formulations Private Limited
About Gorakh Nath Formulations Private Limited
Data last updated:
Gorakh Nath Formulations Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC043224. Its GSTIN is 09AAECG0881E1ZP (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.21 Cr. It is led by directors including Brij Mohan and Saransh Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vasu Farm House Khasra No. 93 Sundra (Puttha) Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103.
As per the financials filed for FY 2024, the company reported a revenue of ₹89.91 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.92 Cr (net margin 2.1%) and EBITDA of ₹4.97 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹16.91 Cr and satisfied charges of ₹9.35 Cr on record. The company has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017. Its 6 peer companies in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 5 smaller; the largest is Himachal Polyolefins Limited with revenue of ₹91.05 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers.
Gorakh Nath Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0004674). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Gorakh Nath Formulations
Contact details
Gorakh Nath Formulations Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVasu Farm House Khasra No. 93 Sundra (Puttha) Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gorakh Nath Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gorakh Nath Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gorakh Nath Formulations Private Limited, buy the company report.
Financials of Gorakh Nath Formulations Private Limited
FY 2025 filings availableGorakh Nath Formulations Private Limited reported revenue of ₹89.91 Cr (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gorakh Nath Formulations Private Limited, buy the company report.
Board of directors of Gorakh Nath Formulations Private Limited
Gorakh Nath Formulations has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Mohan | Director | 15 Jul 2011 | 15 Years 3 Months | Current |
| Saransh Agarwal | Director | 19 Apr 2018 | 8 Years 6 Months | Current |
| Amit Gupta | Director | 15 Jul 2011 | 15 Years 3 Months | Current |
Peer comparison
Gorakh Nath Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Himachal Polyolefins Limited | ₹91.05 Cr (FY 2025) | 30.0% | Sirmaur, Himachal Pradesh, India | |||
| Gorakh Nath Formulations Private Limitedthis company | ₹89.91 Cr (FY 2024) | ₹1.92 Cr | 2.1% | -3.0% | Meerut, Uttar Pradesh, India | |
| Agog Pharma Limited | ₹89.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India | |||
| Kunal Conchem Private Limited | ₹89.71 Cr (FY 2025) | -25.0% | New Delhi, Delhi, India | |||
| Alcedo Pharmachem Private Limited | ₹89.55 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | 263.0% | New Delhi, Delhi, India | |||
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | 6.0% | Andhra Pradesh, India |
To see the full peer comparison of Gorakh Nath Formulations Private Limited, buy the company report.
Auditor
Gorakh Nath Formulations Private Limited is audited by SANJAY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY & CO | FY 2023 | 005135C |
Shareholding
The shareholding of Gorakh Nath Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gorakh Nath Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jan 2023 | 100683777 | Others | ₹1.5 Cr | Open | |
| 20 Jan 2022 | 100542869 | Others | ₹2 Cr | Open | |
| 22 Dec 2020 | 100402812 | Axis Bank Limited | ₹1.15 Cr | Open | |
| 04 Jun 2020 | 100365616 | Others | ₹79.8 Lakh | Open | |
| 08 May 2020 | 100337790 | Others | ₹40 Lakh | Open |
To see the full charge records of Gorakh Nath Formulations Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Gorakh Nath Formulations Private Limited has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: R S Gupta & Sons, 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2014 | Funding round | ₹73 Lakh | Investors: an individual |
| Mar 2014 | Funding round | ₹38.8 Lakh | Investors: 4 individuals |
To see the full deal history of Gorakh Nath Formulations Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Gorakh Nath Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Gorakh Nath Formulations Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Gorakh Nath Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Gorakh Nath Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECG0881E1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AAECG0881E1Z6 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gorakh Nath Formulations Private Limited, buy the company report.
Recent activity
Gorakh Nath Formulations Private Limited has 10 board changes on record since 2011: 3 appointments and 7 cessations. The latest: Saransh Agarwal ceased to be Additional Director on 30 Nov 2021.
17 earlier events are in the company report.
Frequently asked questions
Gorakh Nath Formulations is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2011 (15+ years old) and is registered under CIN U24233UP2011PTC043224.
Gorakh Nath Formulations has 3 current directors:
- Brij Mohan - Director
- Saransh Agarwal - Director
- Amit Gupta - Director
The latest financial statements of Gorakh Nath Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gorakh Nath Formulations is 09AAECG0881E1ZP, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 10AAECG0881E1Z6 (Bihar).
The CIN (Corporate Identification Number) of Gorakh Nath Formulations is U24233UP2011PTC043224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gorakh Nath Formulations was incorporated on 18 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
Gorakh Nath Formulations has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017.
The peers of Gorakh Nath Formulations by revenue are Himachal Polyolefins Limited, Agog Pharma Limited, Kunal Conchem Private Limited, Alcedo Pharmachem Private Limited, Shrey Nutraceuticals and Herbals Private Limited and 1 more, all in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Saransh Agarwal ceased to be Additional Director on 30 Nov 2021. Shantanu Agarwal ceased to be Director on 23 Jun 2018. Saransh Agarwal was appointed as Director on 19 Apr 2018. Gorakh Nath Formulations has 10 board changes on record in total.
Yes, Gorakh Nath Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-UP-56-0004674).
Gorakh Nath Formulations has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers. The latest return was filed on 30 May 2019.
The registered office of Gorakh Nath Formulations is at Vasu Farm House Khasra No. 93 Sundra Puttha Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103.